Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Zeliha Alicikus
Study ID
NCT07222007
Status
Recruiting
Apply to this trial

Conditions

  • Airway Management
  • Critically Ill
  • Intubation Complication
  • Ketamine
  • Oxygenation
  • Propofol

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • induction type for intubation in ICU — PROCEDURE
    Clinical data documented throughout the course of hospitalization will be retrieved and analyzed.

Study Details

The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.

Key Dates

Start date
Apr 18, 2026
Status verified
Apr 2026
Primary completion
Jun 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
4 participants (estimated)

Arms

  • Arm: propofol
    required induction of the following agent in ICU patient
  • Arm: ketamine
    required induction of the following agent in ICU patient
  • Arm: ethomidate
    required induction of the following agent in ICU patient
  • Arm: midazolam
    required induction of the following agent in ICU patient

Primary Outcome Measure

Primary Outcome will be all-cause mortality at day 7 following tracheal intubation [ Time Frame: day 7 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UF Health Jacksonville (Shands Hospital)JacksonvilleFlorida32209
TOLGA Saraçoğlu, prof,md
[email protected]
904-524-5932

Find similar trials in Jacksonville, FL

By research site
UF Health Jacksonville (Shands Hospital)· Jacksonville, FL

Related Studies